{
    "2019-03-26": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Bayer & JNJ Settle Numerous Xarelto Lawsuits for $775 Million",
                "features": {
                    "keywords": [
                        "Bayer",
                        "JNJ",
                        "Xarelto",
                        "lawsuits",
                        "settle"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Amid talk of buyout, Peninsula biotech zeroes in on its blood-thinner antidote",
                "features": {
                    "keywords": [
                        "buyout",
                        "Peninsula",
                        "biotech",
                        "blood-thinner",
                        "antidote"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-03-26",
                "original_text": "Purdue Pharma agrees to $270 million settlement in Oklahoma opioid case",
                "features": {
                    "keywords": [
                        "Purdue",
                        "Pharma",
                        "opioid",
                        "case",
                        "settlement"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-03-26",
                "original_text": "5 Must-See Stock Charts: Oil, JNJ, BBBY, CCL, and NIO",
                "features": {
                    "keywords": [
                        "Stock",
                        "Charts",
                        "Oil",
                        "JNJ",
                        "BBBY",
                        "CCL",
                        "NIO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "retail",
                        "energy",
                        "automotive"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-26",
                "original_text": "Dow Jones Climbs As One Of Its Maligned Stocks Nears Buy Point",
                "features": {
                    "keywords": [
                        "Dow",
                        "Jones",
                        "Climbs",
                        "Maligned",
                        "Stocks",
                        "Buy",
                        "Point"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "market index"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-26",
                "original_text": "OxyContin Maker Purdue Pharma Agrees to $270 Million Settlement With Oklahoma",
                "features": {
                    "keywords": [
                        "OxyContin",
                        "Purdue",
                        "Pharma",
                        "Settlement",
                        "Oklahoma"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-03-26",
                "original_text": "Health Care Sector Update for 03/26/2019: ALDX, ZOM, CANF, NNVC, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health",
                        "Care",
                        "Sector",
                        "Update",
                        "ALDX",
                        "ZOM",
                        "CANF",
                        "NNVC",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-26",
                "original_text": "OxyContin maker Purdue agrees to settle Oklahoma opioid case - source",
                "features": {
                    "keywords": [
                        "OxyContin",
                        "maker",
                        "Purdue",
                        "settles",
                        "Oklahoma",
                        "opioid",
                        "case"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-03-26",
                "original_text": "Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know",
                "features": {
                    "keywords": [
                        "Johnson",
                        "&",
                        "Johnson",
                        "JNJ",
                        "Dips",
                        "Broader",
                        "Markets"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}